This Fund’s $381 Million Top Healthcare Stock Holdings: JNJ, BAX, NVS, GSK

Wall St. Watchdog reveals information regarding Tweedy Browne’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 4 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $381.587 million.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Tweedy Browne reported holding 2,974,366 shares with a market value of $197,854,816. This comprised 6.91% of the total portfolio. On 09/30/2011, Tweedy Browne reported holding 3,198,841 shares with a market value of $203,734,179. This comprised 8.36% of the total portfolio. The net change in shares for this position over the two quarters is 224,475. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, Tweedy Browne reported holding 2,988,245 shares with a market value of $178,368,340. This comprised 6.22% of the total portfolio. On 09/30/2011, Tweedy Browne reported holding 2,714,692 shares with a market value of $152,402,807. This comprised 6.26% of the total portfolio. The net change in shares for this position over the two quarters is -273,553. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Novartis Ag (NYSE:NVS): On 06/30/2011, Tweedy Browne reported holding 350,100 shares with a market value of $21,394,611. This comprised 0.75% of the total portfolio. On 09/30/2011, Tweedy Browne reported holding 346,697 shares with a market value of $19,335,292. This comprised 0.79% of the total portfolio. The net change in shares for this position over the two quarters is -3,403. About Company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Tweedy Browne reported holding 186,452 shares with a market value of $7,998,791. This comprised 0.28% of the total portfolio. On 09/30/2011, Tweedy Browne reported holding 148,093 shares with a market value of $6,114,760. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -38,359. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders

(Note: Data regarding Tweedy Browne’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet